Equities

Ngl Fine Chem Ltd

NGLFINE:NSI

Ngl Fine Chem Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,043.50
  • Today's Change-26.50 / -1.28%
  • Shares traded2.72k
  • 1 Year change+13.09%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 10:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Ngl Fine Chem Ltd grew revenues 21.79% from 2.78bn to 3.39bn while net income improved 101.58% from 204.96m to 413.17m.
Gross margin52.02%
Net profit margin11.73%
Operating margin11.42%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, cash reserves at Ngl Fine Chem Ltd fell by 74.33m. However, the company earned 204.65m from its operations for a Cash Flow Margin of 6.04%. In addition the company used 268.17m on investing activities and also paid 10.81m in financing cash flows.
Cash flow per share62.43
Price/Cash flow per share32.73
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Ngl Fine Chem Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 101.58%. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)--
Div growth rate (5 year)0.00%
Payout ratio (TTM)2.57%
EPS growth(5 years)15.47
EPS (TTM) vs
TTM 1 year ago
47.53
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.